tiprankstipranks
Trending News
More News >
Aurobindo Pharma Ltd (IN:AUROPHARMA)
:AUROPHARMA
India Market
Advertisement

Aurobindo Pharma Ltd (AUROPHARMA) Income Statement

Compare
0 Followers

Aurobindo Pharma Ltd Income Statement

Last quarter (Q4 2025), Aurobindo Pharma Ltd's total revenue was ₹83.82B, an increase of 10.58% from the same quarter last year. In Q4, Aurobindo Pharma Ltd's net income was ₹9.03B. See Aurobindo Pharma Ltd’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
₹ 317.24B₹ 290.02B₹ 246.17B₹ 233.67B₹ 247.75B
Gross Profit
₹ 186.97B₹ 160.16B₹ 129.75B₹ 69.38B₹ 80.49B
Operating Expenses
₹ 44.76B₹ 55.66B₹ 101.80B₹ 92.51B₹ 94.70B
Depreciation and Amortization
₹ 16.49B₹ 14.92B₹ 12.45B₹ 11.27B₹ 10.55B
EBITDA
₹ 66.05B₹ 61.79B₹ 40.09B₹ 45.36B₹ 85.29B
Operating Income
₹ 142.22B₹ 104.50B₹ 25.51B₹ 33.00B₹ 44.76B
Other Income/Expenses
₹ -91.56B₹ -60.70B₹ 610.30M₹ 724.70M₹ 28.67B
Pretax Income
₹ 50.66B₹ 43.80B₹ 26.13B₹ 33.73B₹ 73.44B
Net Income
₹ 34.86B₹ 31.73B₹ 19.27B₹ 26.48B₹ 53.35B
Per Share Metrics
Basic EPS
₹ 59.81₹ 54.16₹ 32.90₹ 45.20₹ 91.05
Diluted EPS
₹ 59.81₹ 54.15₹ 32.90₹ 45.20₹ 91.05
Weighted Average Shares Outstanding
582.83M 585.85M 585.94M 585.94M 585.94M
Weighted Average Shares Outstanding (Diluted)
582.83M 585.94M 585.94M 585.94M 585.94M
Currency in INR

Aurobindo Pharma Ltd Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis